Chondrosarcoma

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone

Proton Beam Therapy for Chondrosarcoma

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas

Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery

Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base

Clear Cell Chondrosarcoma in Italy

PET-imaging of Two Vartumabs in Patients With Solid Tumors

Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial

AG-120 in People With IDH1 Mutant Chondrosarcoma

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

Long-Term Longitudinal QoL in Patients Undergoing EEA

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers

The Registry of Oncology Outcomes Associated with Testing and Treatment

A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors